^
Association details:
| Biomarker: | ER negative |
|---|---|
| Cancer: | Breast Cancer |
| Drug: | toremifene (Selective estrogen receptor modulator) |
| Direction: | Resistant |
Evidence:
Source:
Excerpt:
First line hormone treatment of hormone-dependent metastatic breast cancer in postmenopausal patients. Fareston is not recommended for patients with estrogen receptor negative tumours.
